Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 923-511-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
No studies on toxicokinetics of GLS exist and therefore toxicokinetic evaluation was made using constituent based approach. Majority of GLS components, hydroxides, carbonates, oxidized sulfur compounds and calcium, sodium, potassium, magnesium and manganese cations are normal and essential constituents in mammalian cells and body fluids and their concentration in the blood and tissues is strictly controlled by absorption and excretion. Therefore, under normal body physiology and handling conditions they are not likely to cause toxic effects. Carbonate and hydroxide ions in GLS could potentially affect the acid-base balance of the body. Due to their corrosive properties in high concentrations the alkalis might cause burns to the skin and therefore facilitate the exposure of GLS to the body.
GLS is rich in Ca CO3 when dry. Carbonate ions in GLS will be neutralised in the stomach due to the low pH of the gastric acid or by the bicarbonate buffer system in the blood and the interstitial fluid of vertebrates. Normal plasma concentration of carbonate as bicarbonate HCO3-is 500 -570 mg/l. The excess of HCO3-is excreted in the urine by the kidney to restore the acid-base balance. Due to the alkaline properties of carbonates irritation of the respiratory tract or skin is possible after inhalation of carbonate dust or dermal exposure. However, absorption through intact skin or through inhalation is likely to be negligible.
The main concerns arise from inhalation exposure of dried GLS dust. Airborne particulate matters are considered hazardous to the lungs and general health when the particles are less than five micrometres in diameter, as such particles are not filtered out by the upper respiratory tract. In high exposure concentrations impaired clearance may result in accumulation of particles in the lung (ie, lung overload). Deposition of particles onto the respiratory epithelium can lead to inflammatory response, cell injury, cell proliferation, production of reactive oxygen species, fibrosis, genotoxic effects, and even cancer. Fine and ultrafine carbon black particles have been shown to translocate beyond the lungs to other organs and particles smaller than 2.5 micrometers can cause high plaque deposits in arteries, causing cardiovascular problems. Lung diseases or conditions may influence the deposition and retention of particles. GLS dust is likely to contain at least carbon particles ofunburned coal or soot fraction of GLS. The median particle size (L50) of GLS deduced from the particle size distributions is 468.4 µm, and 10 % of the particles is under 9.1 µm. Thus GLS is not likely to be absorbed in significant amounts in the body through inhalation or deposit in the lungs under proper handling conditions. However, other elements and chemical compounds may be associated with the particulate carbon, such as toxicologically potent unsubstituted polycyclic aromatic hydrocarbons (PAHs). The amount of PAHs was not determined for this report, but according to a previous study by Enell et al. 2008, discussed in the Chapter 1.2, Composition of the substance), PAHs can be found only in trace amounts (< 0.1 %) in GLS. Nevertheless,they are likely to be tightly bound to carbon particles and not bioavailable.In addition to carbon,inorganic manganese compounds can exist in the air as aerosols or suspended particulate matter.Manganese from smaller particles(< 2.5 microns)is mainly absorbed into blood and lymph fluids, while manganese from larger particles placed in the nasal mucosa may be directly transported to the brain. Alternatively, particles deposited in the upper or lower respiratory tract may be moved by mucociliary transport to the throat and swallowed.Exposure of manganese in larger amounts or chronically, especially by inhalation, can cause neurological damage in mammals.Since manganese is eliminated from the body mainly through bile, impairments in the liver function may limit the ability of the body to excrete manganese.
Some toxicologically very potent compounds, such as sulphides, nickel, lead and cadmium can be found in GLS in trace amounts (<0.1 %) depending on the mill processes. However, since their very low concentrations in GLS their toxicokinetic characteristics are not discussed here.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.